Kala Pharmaceuticals (KALA) Reports In-Line Q1 EPS, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as higher yields and oil prices flag inflation risk
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Lynx sees AI semiconductor rally extending into year-end
| (NASDAQ: KALA) | Delayed: 0.32 -0.04 (11.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.36 | 52 Week High | $ | |||
| Open | $0.35 | 52 Week Low | $ | |||
| Day High | $0.35 | P/E | N/A | |||
| Day Low | $0.32 | EPS | $ | |||
| Volume | 180,546 | |||||
